Marc Humbert

Professeur des Universités Praticien Hospitalier

Université Paris-Saclay

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Marc Humbert is a Praticien Hospitalier at COMUE Université Paris-Saclay in France. His research primarily focuses on pulmonary hypertension, including the clinical management of conditions such as chronic obstructive pulmonary disease and pulmonary arterial hypertension. Recent articles authored by Professor Humbert encompass topics such as patient-centred approaches, insights from clinical trials, and novel methodologies in diagnosing and treating pulmonary vascular diseases.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

David Montani

Université de Paris Faculté de Santé

FRANCE

Marc Humbert

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Clustering Patients with Pulmonary Hypertension Using the Plasma Proteome

Pericardial effusion in sotatercept phase 3 trials: insights from STELLAR and ZENITH

A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA

Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited: A Multigenerational Perspective

Pulmonary vascular resistance to define severe pulmonary hypertension: cutting the Gordian knot

A person-centred clinical approach to the multimorbid patient with COPD

SOX17 in pulmonary arterial hypertension: from development to clinical phenotype

Severe Hypoxemia and Pulmonary Capillary Dilatations in Pulmonary Arterial Hypertension Patients Treated with Sotatercept

Detection and Evaluation of Drug-associated Pulmonary Arterial Hypertension

Diagnosis and management of pulmonary veno-occlusive disease

The European Reference Network on Rare Lung Diseases (ERN-LUNG) ambition to offer better lung health for all

The central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension

Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants

Inhaled treprostinil for interstitial lung disease-associated pulmonary hypertension: a silver lining on a very dark cloud

Physiopathologie et traitements de l’hypertension artérielle pulmonaire

The flare of care for rare: per aspera ad astra for rare lung diseases!

The ‘Ten Commandments’ of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Collaborators (19)

David Montani

Roger Thompson

Abebaw Yohannes

Frédéric Perros

Kenzo Ichimura

Vincent Cottin

Marion Delcroix

Sanjeev Bhalla

Ioana Preston

Frederikus A. Klok

Olivier SITBON

Alice Huertas

Claudia Valenzuela

Katarina Zeder

Etienne-Marie Jutant

Catherine Simpson

ALBERTO PAPI

Edda Spiekerkoetter

George Giannakoulas

Make your next move.